OR WAIT null SECS
Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.
May 18, 2023
Waters Corporation expected to boost growth in bioanalytical characterization for new modalities with acquisition of Wyatt Technology.
May 16, 2023
A good understanding of tablet tooling and how to properly maintain these key parts will maximize lifespan of tools.
May 11, 2023
EC has granted marketing authorization to Chiesi Global Rare Diseases and Protalix BioTherapeutics for PRX-102 (pegunigalsidase alfa).
Critical raw materials supplier, Biosynth, has acquired UK-based Cambridge Research Biochemicals (CRB).
Vetter is further expanding its production capacity and services at its Rankweil, Austria site.
May 02, 2023
Guidance for GMP manufacture of emerging therapies has evolved to accommodate innovation and the broader spectrum of products in development, but greater harmonization is still needed.